The RADAR programme aims to test if new pre-emptive therapeutic development and clinical care strategies based on remote continuous monitoring are both scientifically feasible and also practically feasible as part of a wider healthcare system. Early stages of Alzheimer’s Disease (AD) are associated with cognitive decline, overlapping with increasing functional decline (impairments in the ability

RATE-AF is an National Institute for Health Research (NIHR) funded study designed to compare two strategies of rate-control, based either on initial treatment with digoxin or beta-blockers in 160 patients with Atrial fibrillation (AF) in need for rate-control therapy. Monitoring with wearable devices, phone sensors and questionnaires will be conducted over a continuous 6 month

Multiple sclerosis (MS) is a condition in which the body’s immune system has an abnormal reaction to the central nervous system (CNS, made up of the brain, spinal cord and optic nerves). The immune system attacks elements of the CNS, disrupting the transmission of nerve signals and producing the symptoms that characterise MS. The exact

The MDD study is focused on the remote data collection aspect, since the study participants are not monitored in a hospital setting, but the data is collected passively in an real life assessment. Besides the sensor data from smartphones and wearables devices, participants actively report mood at random time points in daily life, using the

The epilepsy studies are running in University hospitals in the UK and in Germany. Goal of those pilot studies is the evaluation of wearable device data for passive remote monitoring of patients in an hospital epilepsy monitoring unit (EMU). The RADAR-base Android application, captures sensor data from consumer grade and medical grade wearables devices via